trending Market Intelligence /marketintelligence/en/news-insights/trending/9dyY8pqJXwNyiP8SAfzkRg2 content esgSubNav
In This List

Tandem Diabetes closes common stock, warrants offering

Blog

Perspectivas América Latina 2023 Emerging Trends & Growth

Blog

Insight Weekly: SVB fallout limited; US rents up; renewable natural gas investments flow in

Blog

A Cloud Migration Plan for Corporations featuring Snowflake®

Blog

Investor Activism Campaigns Hit Record High in 2022


Tandem Diabetes closes common stock, warrants offering

Tandem Diabetes Care Inc. closed its public offering of 4,630,000 common shares as well as series A and series B warrants at $3.50 apiece with expected net proceeds of about $14.8 million.

Each common share comes bundled with the two warrants, each to purchase an additional stock in the company for $3.50 apiece.

The net proceeds will be used for working capital and general corporate purposes.

Oppenheimer & Co. Inc. acted as the sole book-running manager for the offering. National Securities Corp. acted as co-manager.